πŸ‡ΊπŸ‡Έ FDA
Patent

US 9701611

Salts of treprostinil

granted A61PA61P9/12

Quick answer

US patent 9701611 (Salts of treprostinil) held by United Therapeutics Corporation expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P9/12